189 related articles for article (PubMed ID: 22260853)
1. Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization.
Gracia CR; Morse CB; Chan G; Schilling S; Prewitt M; Sammel MD; Mandel SJ
Fertil Steril; 2012 Mar; 97(3):585-91. PubMed ID: 22260853
[TBL] [Abstract][Full Text] [Related]
2. Thyroid function modifications in women undergoing controlled ovarian hyperstimulation for in vitro fertilization: a systematic review and meta-analysis.
Busnelli A; Cirillo F; Levi-Setti PE
Fertil Steril; 2021 Jul; 116(1):218-231. PubMed ID: 33838869
[TBL] [Abstract][Full Text] [Related]
3. Maternal thyroid function in women undergoing controlled ovarian hyperstimulation during in-vitro fertilization and its relation to reproductive outcome.
Abdul Karim AK; Azrai Abu M; Chelliah B; Mohd Razi ZR; Omar MH; Othman H; Man ZC
Minerva Ginecol; 2017 Oct; 69(5):431-437. PubMed ID: 28447444
[TBL] [Abstract][Full Text] [Related]
4. Thyroid axis dysregulation during in vitro fertilization in hypothyroid-treated patients.
Busnelli A; Somigliana E; Benaglia L; Sarais V; Ragni G; Fedele L
Thyroid; 2014 Nov; 24(11):1650-5. PubMed ID: 25089619
[TBL] [Abstract][Full Text] [Related]
5. THE LONG-TERM IMPACT OF CONTROLLED OVARIAN HYPERSTIMULATION ON THYROID FUNCTION.
Busnelli A; Somigliana E; Ferrari S; Filippi F; Vannucchi G; Fugazzola L; Fedele L
Endocr Pract; 2016 Apr; 22(4):389-95. PubMed ID: 26574787
[TBL] [Abstract][Full Text] [Related]
6. Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease.
Magri F; Capelli V; Gaiti M; Brambilla E; Montesion L; Rotondi M; Spinillo A; Nappi RE; Chiovato L
Thyroid; 2013 Oct; 23(10):1312-8. PubMed ID: 23556516
[TBL] [Abstract][Full Text] [Related]
7. Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization.
Benaglia L; Busnelli A; Somigliana E; Leonardi M; Vannucchi G; De Leo S; Fugazzola L; Ragni G; Fedele L
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():53-7. PubMed ID: 24332278
[TBL] [Abstract][Full Text] [Related]
8. Effects of controlled ovarian stimulation on thyroid stimulating hormone in infertile women.
Du YJ; Xin X; Cui N; Jiang L; Yang AM; Hao GM; Gao BL
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():207-212. PubMed ID: 30731333
[TBL] [Abstract][Full Text] [Related]
9. Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist.
Lyttle Schumacher BM; Mersereau JE; Steiner AZ
Fertil Steril; 2018 Apr; 109(4):633-637. PubMed ID: 29605403
[TBL] [Abstract][Full Text] [Related]
10. The effect of infertility medication on thyroid function in hypothyroid women who conceive.
Davis LB; Lathi RB; Dahan MH
Thyroid; 2007 Aug; 17(8):773-7. PubMed ID: 17725435
[TBL] [Abstract][Full Text] [Related]
11. In vitro fertilization outcomes in treated hypothyroidism.
Busnelli A; Somigliana E; Benaglia L; Leonardi M; Ragni G; Fedele L
Thyroid; 2013 Oct; 23(10):1319-25. PubMed ID: 23544891
[TBL] [Abstract][Full Text] [Related]
12. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.
Styer AK; Gaskins AJ; Brady PC; Sluss PM; Chavarro JE; Hauser RB; Toth TL
Fertil Steril; 2015 Nov; 104(5):1153-61.e1-7. PubMed ID: 26315051
[TBL] [Abstract][Full Text] [Related]
13. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.
Zhu X; Ye H; Fu Y
Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446
[TBL] [Abstract][Full Text] [Related]
14. Prior iodine exposure and impact on thyroid function during controlled ovarian hyperstimulation: A prospective study.
Bradbury RA; Christie-David D; Smith HC; Byth K; Eastman CJ
Aust N Z J Obstet Gynaecol; 2022 Feb; 62(1):133-139. PubMed ID: 34406645
[TBL] [Abstract][Full Text] [Related]
15. Iron deficiency anaemia in childhood and thyroid function.
Tienboon P; Unachak K
Asia Pac J Clin Nutr; 2003; 12(2):198-202. PubMed ID: 12810411
[TBL] [Abstract][Full Text] [Related]
16. Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls.
De Geyter C; Steimann S; Müller B; Kränzlin ME; Meier C
Thyroid; 2009 Jan; 19(1):53-9. PubMed ID: 18976152
[TBL] [Abstract][Full Text] [Related]
17. Randomized, assessor-blind, antimüllerian hormone-stratified, dose-response trial in Japanese in vitro fertilization/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta.
Ishihara O; Klein BM; Arce JC;
Fertil Steril; 2021 Jun; 115(6):1478-1486. PubMed ID: 33272623
[TBL] [Abstract][Full Text] [Related]
18. Changes in thyroid function during controlled ovarian hyperstimulation (COH) and its impact on assisted reproduction technology (ART) outcomes: a systematic review and meta-analysis.
Li D; Hu S; Meng X; Yu X
J Assist Reprod Genet; 2021 Sep; 38(9):2227-2235. PubMed ID: 33928487
[TBL] [Abstract][Full Text] [Related]
19. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Nyboe Andersen A; Nelson SM; Fauser BC; García-Velasco JA; Klein BM; Arce JC;
Fertil Steril; 2017 Feb; 107(2):387-396.e4. PubMed ID: 27912901
[TBL] [Abstract][Full Text] [Related]
20. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
